Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children

Diabetes

Volumn 49, Issue 1, 2000, Pages 48-58

  Kulmala, Petri ^a   Savola, Kaisa ^a   Reijonen, Helena ^b   Veijola, Riitta ^a   Vähäsalo, Paula ^a   Karjalainen, Jukka ^a   Tuomilehto Wolf, Eva ^c   Ilonen, Jorma ^b   Tuomilehto, Jaakko ^c   Åkerblom, Hans K ^c   Knip, Mikael ^a,d  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; FEMALE; GENETIC MARKER; GENOTYPE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; SIBLING;

EID: 0033964734     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.1.48     Document Type: Article

References (46)

1. Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingley PJ, Rogge L, Pastore MR, Bognetti E, Bottazzo GF, Gale EAM, Bosi E: Islet autoantibody markers in IDDM. risk assessment strategies yielding high sensitivity. Diabetologia 38:816-822, 1995
2. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933, 1996
3. Christie MR, Roll U, Payton MA, Hatfield ECI, Ziegler A-G: Validity of screening for individuals at risk for type 1 diabetes by combined analysis of antibodies to recombinant proteins. Diabetes Care 20:965-970, 1987
4. Hawa M, Rowe R, Lan MS, Notkins AL, Pozzilli P, Christie MR, Leslie RDG: Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes. Diabetes 46:1270-1275, 1997
5. Dittler J, Seidel D, Schenker M, Ziegler A-G: GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives. Diabetes 47:592-597, 1998
6. Pastore MR, Bazzigaluppi E, Bonfanti R, Dozio N, Sergi A, Balini A, Belloni C, Meschi F, Bonifacio E, Bosi E: Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives. Diabetes Care 21:1445-1450, 1998
7. Kulmala P, Savola K, Petersen JS, Vähäsalo P, Karjalainen J, Löppönen T, Dyrberg T, Åkerblom HK, Knip M, the Childhood Diabetes in Finland Study Group: Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes: a population based study. J Clin Invest 101:327-336, 1998
8. Singal DP, Blajchman MA: Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes 22:429-432, 1973
9. Nerup J, Platz P, Andersen OO, Christy M, Lyngsoe J, Poulsen JE, Ryder LP, Nielsen LS, Thomsen M, Svejgaard A: HL-A antigens and diabetes mellitus. Lancet ii:864-866, 1974
10. Solow H, Hidalgo R, Singal DP: Juvenile-onset diabetes: HLA-A, -B, -C, and -DR alloantigens. Diabetes 28:1-4, 1979
11. Ilonen J, Herva E, Tiilikainen A, Åkerblom HK, Koivukangas T, Kouvalainen K: HLA-Dw2 as a marker of resistance against juvenile diabetes mellitus. Tissue Antigens 11:144-146, 1978
12. Wassmuth R, Lernmark Å : The genetics of susceptibility to diabetes. Clin Immunol Immunopathol 53:358-399, 1989
13. Deschamps I, Khalil I: The role of DQ alpha-beta heterodimers in genetic susceptibility to insulin-dependent diabetes. Diabetes Metab Rev 9:71-92, 1993
14. Owerbach D, Lernmark Å , Platz P, Ryder LP, Rask L, Peterson PA, Ludvigsson J: HLA-D region b-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature 303:815-817, 1983
15. Nepom BS, Palmer J, Kim SJ, Hansen JA, Holmbeck SL, Nepom GT: Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis. J Exp Med 164:345-1350, 1986
16. Morel PA, Dorman JS, Todd JA, McDevitt HO, Trucco M: Aspartic acid at position 57 of the HLA-DQ b chain protects against type I diabetes: a family study. Proc Natl Acad Sci U S A 85:8111-8115, 1988
17. Böhme J, Carlsson B, Wallin JME, Persson B, Peterson PA, Rask L: Only one DQ-b restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J Immunol 137:941-947, 1986
18. Ziegler R, Alper CA, Awdeh ZL, Castano L, Brink SJ, Soeldner JS, Jackson RA, Eisenbarth GS: Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type 1 diabetes. Diabetes 40:709-714, 1991
19. Pugliese A, Bugawan T, Moromisato R, Awdeh ZL, Alper CA, Jackson RA, Erlich HA, Eisenbarth GS: Two subsets of HLA-DQA1 alleles mark phenotypic variation in levels of insulin autoantibodies in first degree relatives at risk for insulin-dependent diabetes. J Clin Invest 93:2447-2452, 1994
20. Vandewalle CL, Falorni A, Lernmark Å, Goubert P, Dorchy H, Coucke W, Semakula C, Van Der Auwera B, Kaufman L, Schuit FC, Pipeleers DG, Gorus FK, the Belgian Diabetes Registry: Associations of GAD65-and IA-2-autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. Diabetes Care 20:1547-1552, 1997
21. Tarn AC, Thomas JM, Dean BM, Ingram D, Schwarz G, Bottazzo GF, Gale EAM: Predicting insulin-dependent diabetes. Lancet i:845-850, 1988
22. Sheeny MJ, Scharf SJ, Rowe JR, Neme De Gimenez MH, Meske LM, Erlich HA, Nepom BS: A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest 83:830-835, 1989
23. Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD: Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med 322:1836-1841, 1990
24. Deschamps I, Boitard C, Hors J, Busson M, Marcelli-Barge A, Mogenet A, Robert JJ: Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers: an 8-year prospective study. Diabetologia 35:951-957, 1992
25. Lipton RB, Kocova M, LaPorte RE, Dorman JS, Orchard TJ, Riley WJ, Drash AL, Becker DJ, Trucco M: Autoimmunity and genetics contribute to the risk of insulin-dependent diabetes mellitus in families: islet cell antibodies and HLA DQ heterodimers. Am J Epidemiol 136:503-512, 1992
26. Reijonen H, Vähäsalo P, Karjalainen J, Ilonen J, Åkerblom HK, Knip M, the Childhood Diabetes in Finland (DiMe) Study Group: HLA-DQB1 genotypes and islet cell antibodies in the identification of siblings at risk for insulin-dependent diabetes (IDDM) in Finland. J Autoimmun 7:675-686, 1994
27. Karjalainen J, Vähäsalo P, Knip M, Tuomilehto-Wolf E, Virtala E, Åkerblom HK, the Childhood Diabetes in Finland Study Group: Islet cell autoimmunity and progression to insulin-dependent diabetes mellitus in genetically high-and low-risk siblings of diabetic children. Eur J Clin Invest 26:640-649, 1996
28. Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E, Reunanen A, Virtala E, Kaprio EA, Åkerblom HK, the Childhood Diabetes in Finland Study Group: Epidemiology of childhood diabetes in Finland: background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:70-76, 1992
29. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser, no. 727) p. 10-12
30. Tuomilehto-Wolf E, Tuomilehto J, Cepaitis Z, Lounamaa R, the Childhood Diabetes in Finland Study Group: New susceptibility haplotype for type 1 diabetes. Lancet ii:299-302, 1989
31. Nomenclature for factors of the HLA system. In Histocompatibility Testing 1984. Albert ED, Mayr WR, Eds. Berlin, Springer-Verlag, 1984, p. 4-8
32. Sjöroos M. Iitiä A, Ilonen J, Reijonen H, Lövgren T: Triple-label hybridization assay for type-1 diabetes-related HLA alleles. Biotechniques 18:870-877, 1995
33. Ilonen J, Reijonen H, Herva E, Sjöroos M, Iitiä A, Lövgren T, Veijola R, Knip M, Åkerblom HK, the Childhood Diabetes in Finland Study Group: rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. Diabetes Care 19:795-800, 1996
34. Bottazzo GF, Florin-Christenscn A, Doniach D: Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet ii: 1279-1282, 1974
35. Greenbaum CJ, Palmer JP, Nagataki S, Yamaguchi Y, Molenaar JL, VanBeers WAM, Maclaren NK, Lernmark Å, and participating laboratories: Improved specificity of ICA assays in the Fourth International Immunology of Diabetes Serum Exchange Workshop. Diabetes 41:1570-1574, 1992
36. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E: Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol 155:5419-5426, 1995
37. Savola K, Bonifacio E, Sabbah E, Kulmala P, Vähäsalo P, Karjalainen J, Tuomilehto-Wolf E, Meriläinen J, Åkerblom HK, Knip M, the Childhood Diabetes in Finland Study Group: IA-2 antibodies: a sensitive marker of IDDM. A study in children and adolescents with newly diagnosed diabetes. Diabetologia 41:424-429, 1998
38. Verge CF, Stenger D, Bonifacio E, Colnian PG, Pilcher C, Bingley PJ, Eisenbarth GS, and participating laboratories: Combined use of autoantibodies (IA-2ab, GADab, IAA, ICA) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 47:1857-1866, 1998
39. 63, antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43:459-467, 1994
40. Schmidli RS, Colman PG, Bonifacio E: Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies: the Second International GADAb Workshop. Diabetes 44:635-640, 1995
41. Palmer J, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL: Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222:1337-1339, 1983
42. Shuster JJ: EXACTB and CONF: exact unconditional procedures for binominal data. Am Statist 42:234, 1988
43. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. JASA 53:457-481, 1958
44. Marital N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother 50:163-170, 1966
45. Partanen J, Koskimies S, Ilonen J, Knip M: HLA antigens and complotypes in insulin-dependent diabetes mellitus. Tissue Antigens 27:291-297, 1986
46. Pugliese A, Gianani R, Moromisato R, Awdeh ZL, Alper CA, Erlich HA, Jackson RA, Eisenbarth GS: HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes 44:608-613, 1995